Market Overview:
The global reverse transcriptase market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for reverse transcriptase in various applications such as PCR, sequencing, and cloning. Additionally, the growing demand for nucleic acid-based products is also contributing to the growth of this market. On the basis of type, MMLV reverse transcriptase held a major share of the global reverse transcriptase market in 2017. This segment is expected to continue its dominance during the forecast period owing to its high efficiency and accuracy.
Product Definition:
A reverse transcriptase is an enzyme that catalyzes the conversion of RNA into DNA. Reverse transcriptases are used in molecular biology to convert mRNA into cDNA, which can then be amplified by PCR. The importance of reverse transcriptases lies in their ability to allow researchers to study the expression of genes without needing to isolate and purify RNA.
MMLV Reverse Transcriptase:
MMLV reverse transcriptase is an enzyme that catalyzes the conversion of mRNA to DNA which can be used for the synthesis of cDNA. It is also known as RT or rt reverse transcriptase. The mechanism by which it works is by converting RNA to DNA, this process allows researchers and scientists to study gene expression in a cell with out affecting the original genetic information.
AMV Reverse Transcriptase:
Reverse transcriptase is an enzyme that converts the RNA in DNA. It is used for the conversion of mRNA toDNA which can be used for PCR (polymerase chain reaction). AMV reverse transcriptase also known as Alu-Alu reverse transcriptase or AAV-RT, is an enzyme that catalyzes the reverse transcription of RNA into DNA.
Application Insights:
The sequencing application segment accounted for the largest revenue share in 2017. The use of reverse transcriptase has helped in sequencing a number of viruses, including HIV, SARS-CoV-2, and CMV. The advent of second and third generation DNA sequencing technologies has also played a key role in increasing the depth of coverage provided by the market for rt-dT services.
PCR is estimated to be the fastest growing application over the forecast period owing to its ability to provide highly specific targets with high sensitivity at low costs as compared to other methods such as Southern Blotting or Northern Blotting.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of well-established healthcare facilities, increasing adoption of advanced technologies, and high demand for rapid diagnostic solutions. Moreover, rising prevalence of chronic diseases such as cancer is expected to boost the usage rates for RT PCR products in North America over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as improving healthcare infrastructure and growing patient awareness regarding early diagnosis & treatment options leading towards improved health outcomes at lower costs associated with these services demand hassles & risks involved along with better treatment results faster recovery time reduced hospital stays etcetera which will drive revenue generation through sales/licensing or distribution agreements between service providers and manufacturers respectively.
Growth Factors:
- Increasing demand for nucleic acid sequencing and gene expression profiling
- Rising prevalence of cancer and other diseases
- Growing use of RT in drug discovery and development processes
- Advances in RT technology and increasing demand for custom-made enzymes
- Proliferation of next-generation sequencing platforms
Scope Of The Report
Report Attributes
Report Details
Report Title
Reverse Transcriptase Market Research Report
By Type
MMLV Reverse Transcriptase, AMV Reverse Transcriptase
By Application
PCR, Sequencing, Cloning
By Companies
Thermo Fisher, Promega, Roche, Bio-Rad, Takara Bio, Agilent, Qiagen, Fapon Biotech, Toyobo, Vazyme, New England Biolabs
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Reverse Transcriptase Market Report Segments:
The global Reverse Transcriptase market is segmented on the basis of:
Types
MMLV Reverse Transcriptase, AMV Reverse Transcriptase
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
PCR, Sequencing, Cloning
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher
- Promega
- Roche
- Bio-Rad
- Takara Bio
- Agilent
- Qiagen
- Fapon Biotech
- Toyobo
- Vazyme
- New England Biolabs
Highlights of The Reverse Transcriptase Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- MMLV Reverse Transcriptase
- AMV Reverse Transcriptase
- By Application:
- PCR
- Sequencing
- Cloning
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Reverse Transcriptase Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Reverse transcriptase is a process that helps create a copy of a gene from RNA.
Some of the major players in the reverse transcriptase market are Thermo Fisher, Promega, Roche, Bio-Rad, Takara Bio, Agilent, Qiagen, Fapon Biotech, Toyobo, Vazyme, New England Biolabs.
The reverse transcriptase market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Reverse Transcriptase Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Reverse Transcriptase Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Reverse Transcriptase Market - Supply Chain
4.5. Global Reverse Transcriptase Market Forecast
4.5.1. Reverse Transcriptase Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Reverse Transcriptase Market Size (000 Units) and Y-o-Y Growth
4.5.3. Reverse Transcriptase Market Absolute $ Opportunity
5. Global Reverse Transcriptase Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Reverse Transcriptase Market Size and Volume Forecast by Type
5.3.1. MMLV Reverse Transcriptase
5.3.2. AMV Reverse Transcriptase
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Reverse Transcriptase Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Reverse Transcriptase Market Size and Volume Forecast by Application
6.3.1. PCR
6.3.2. Sequencing
6.3.3. Cloning
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Reverse Transcriptase Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Reverse Transcriptase Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Reverse Transcriptase Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Reverse Transcriptase Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Reverse Transcriptase Demand Share Forecast, 2019-2026
9. North America Reverse Transcriptase Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Reverse Transcriptase Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Reverse Transcriptase Market Size and Volume Forecast by Application
9.4.1. PCR
9.4.2. Sequencing
9.4.3. Cloning
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Reverse Transcriptase Market Size and Volume Forecast by Type
9.7.1. MMLV Reverse Transcriptase
9.7.2. AMV Reverse Transcriptase
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Reverse Transcriptase Demand Share Forecast, 2019-2026
10. Latin America Reverse Transcriptase Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Reverse Transcriptase Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Reverse Transcriptase Market Size and Volume Forecast by Application
10.4.1. PCR
10.4.2. Sequencing
10.4.3. Cloning
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Reverse Transcriptase Market Size and Volume Forecast by Type
10.7.1. MMLV Reverse Transcriptase
10.7.2. AMV Reverse Transcriptase
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Reverse Transcriptase Demand Share Forecast, 2019-2026
11. Europe Reverse Transcriptase Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Reverse Transcriptase Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Reverse Transcriptase Market Size and Volume Forecast by Application
11.4.1. PCR
11.4.2. Sequencing
11.4.3. Cloning
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Reverse Transcriptase Market Size and Volume Forecast by Type
11.7.1. MMLV Reverse Transcriptase
11.7.2. AMV Reverse Transcriptase
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y GrowthProjections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Reverse Transcriptase Demand Share, 2019-2026
12. Asia Pacific Reverse Transcriptase Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Reverse Transcriptase Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Reverse Transcriptase Market Size and Volume Forecast by Application
12.4.1. PCR
12.4.2. Sequencing
12.4.3. Cloning
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Reverse Transcriptase Market Size and Volume Forecast by Type
12.7.1. MMLV Reverse Transcriptase
12.7.2. AMV Reverse Transcriptase
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Reverse Transcriptase Demand Share, 2019-2026
13. Middle East & Africa Reverse Transcriptase Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Reverse Transcriptase Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Reverse Transcriptase Market Size and Volume Forecast by Application
13.4.1. PCR
13.4.2. Sequencing
13.4.3. Cloning
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Reverse Transcriptase Market Size and Volume Forecast by Type
13.7.1. MMLV Reverse Transcriptase
13.7.2. AMV Reverse Transcriptase
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Reverse Transcriptase Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Reverse Transcriptase Market: Market Share Analysis
14.2. Reverse Transcriptase Distributors and Customers
14.3. Reverse Transcriptase Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Thermo Fisher
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Promega
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Roche
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bio-Rad
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Takara Bio
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Agilent
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Qiagen
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Fapon Biotech
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Toyobo
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Vazyme
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. New England Biolabs
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook